Konica Minolta’s Dynamic Digital Radiography technology gains FDA clearance
Konica Minolta Healthcare Americas has gained FDA clearance for its Dynamic Digital Radiography (DDR) imaging technology, which can capture movement and track changes in the body over time.
DDR, first introduced to the world at RSNA 2018 in Chicago, was designed with musculoskeletal and thoracic imaging in mind.
“DDR is a paradigm shift in how x-ray may be utilized throughout the continuum of care, where an essential primary diagnostic tool can now deliver more information so clinicians can visualize anatomic structures and their interaction during movement in a way they have never seen before,” Guillermo Sander, Konica Minolta’s director of digital radiography marketing, said in a prepared statement. “There are immense opportunities for DDR to help clinicians enhance patient management and personalize care with potential cost savings by reducing the need for more advanced and expensive imaging tests.”
Clinicians can use DDR to track lesions as they move throughout a patient’s respiratory cycle, according to the statement, and its ability to quantify movement will help providers treat patients suffering from dyspnea.
Konica Minolta has plans to release DDR to the public later this year.
Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.